Baker McKenzie advises on Keensight Capital’s acquisition of a majority stake in Bedfont Scientific Ltd.
One of the top private equity managers specializing in pan-European Growth Buyout investments, Keensight Capital (Keensight), has received financial advice from Baker McKenzie regarding the financing of its purchase of a majority interest in Bedfont® Scientific Ltd. (Bedfont), a company that develops and produces non-invasive breath analysis medical devices.